Top 10 Performing Stocks To Watch Right Now

tags:DOV,COLM,CDTX,VNET,BCPC,PME,MNR,MTDR,HBHC,CSTM,

Verizon Communications Inc. (NYSE: VZ) replaces Exxon Mobil this week as the worst-performing stock on the Dow Jones Industrial Average (DJIA) index, a position it last held in February. The stock has lost 8.84% for the year to date.

The shares dropped by just 9 cents last week (less than 0.2%), but that was enough to drop the stock to the bottom of the Dow 30.

Investors remain concerned about the hit to revenues that may follow the adoption of the company’s unlimited data plan. With all four major U.S. wireless carriers now offering unlimited data plans, has the industry embarked on a race to the bottom?

Analysts at Jefferies warned:

While the industry remains bullish on growth in data usage, and metered plans allow for some continued enthusiasm, the move by every carrier to unlimited plans will cause carriers to hope for less and less data usage. Almost every pricing action over the last couple of years has continued to take the roof down on ARPU growth opportunities as more and more data was offered for the same, or lower price point. Now with the advent of unlimited plans, the upside from additional usage is gone for those choosing aggressively priced unlimited plans.

Top 10 Performing Stocks To Watch Right Now: Dover Corporation(DOV)

Advisors' Opinion:

• [By Chris Lange]

  The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Dover Corp. (NYSE: DOV) which traded down about 18% at $76.68. The stock's 52-week range is $75.88 to $109.06. Volume was 3.7 million compared to the daily average volume of 1.6 million.

• [By ]

  Dover Corp. (NYSE: DOV) is a diversified global manufacturer of equipment, components, systems and solutions in four segments: engineered systems, fluids, refrigeration and food equipment, and energy. The 2017 hike marked the 62nd consecutive year of hikes. Looking ahead, the company's CEO expects more acquisitions that would contribute to higher margins and completion of the current share buy back program. The 2018 hike marked the 63rd consecutive year of hikes.

• [By ]

  Dover Corp. (NYSE: DOV) spans multiple industries for equipment and components, pumps, conveyors and other items used by manufacturers and goods-producing companies. Its dividend hike in August 2018 marked the 63rd consecutive year of dividend hikes since its founding in 1947.

Top 10 Performing Stocks To Watch Right Now: Columbia Sportswear Company(COLM)

Advisors' Opinion:

• [By Shane Hupp]

  Columbia Sportswear (NASDAQ:COLM) hit a new 52-week high and low during mid-day trading on Tuesday . The stock traded as low as $88.86 and last traded at $88.27, with a volume of 4020 shares traded. The stock had previously closed at $87.29.

• [By Joseph Griffin]

  Schwab Charles Investment Management Inc. trimmed its position in Columbia Sportswear (NASDAQ:COLM) by 15.0% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 218,646 shares of the textile maker’s stock after selling 38,455 shares during the period. Schwab Charles Investment Management Inc. owned about 0.31% of Columbia Sportswear worth $20,000,000 as of its most recent SEC filing.

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Columbia Sportswear (COLM)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Motley Fool Transcribers]

  Columbia Sportswear Co  (NASDAQ:COLM)Q4 2018 Earnings Conference CallFeb. 07, 2019, 4:15 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Shane Hupp]

  Columbia Sportswear (NASDAQ:COLM) had its target price raised by research analysts at Wedbush from $102.00 to $103.00 in a research report issued on Wednesday. The firm presently has an “outperform” rating on the textile maker’s stock. Wedbush’s price target would indicate a potential upside of 13.99% from the company’s current price.

Top 10 Performing Stocks To Watch Right Now: Cidara Therapeutics, Inc.(CDTX)

Advisors' Opinion:

• [By Trey Thoelcke]

  This small-cap biotech company also has big-time potential. Cidara Therapeutics Inc. (NASDAQ: CDTX) is a clinical-stage biotechnology company is engaged in the discovery, development and commercialization of anti-infectives. It is developing a pipeline of product and development candidates with a focus on serious fungal infections.

• [By Joseph Griffin]

  These are some of the news headlines that may have impacted Accern’s scoring:

  Get Cidara Therapeutics alerts: Statement re Appointment of Matthew Onaitis as Chief Financial Officer (businesswire.com) Mainstay Medical Announces the Appointment of Matthew Onaitis as Chief Financial Officer (businesswire.com) Cidara finance chief bids adieu (seekingalpha.com) Cidara Therapeutics Inc (CDTX) Receives Average Recommendation of “Buy” from Brokerages (americanbankingnews.com)

  Shares of CDTX stock traded down $0.05 on Wednesday, hitting $4.35. 6,508 shares of the stock traded hands, compared to its average volume of 98,568. The company has a current ratio of 7.11, a quick ratio of 7.11 and a debt-to-equity ratio of 0.12. The firm has a market cap of $120.40 million, a P/E ratio of -1.37 and a beta of 1.99. Cidara Therapeutics has a 1-year low of $3.65 and a 1-year high of $8.80.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Cidara Therapeutics (CDTX)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Cidara Therapeutics (NASDAQ:CDTX) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.80) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.70) by ($0.10), Bloomberg Earnings reports.

• [By Ethan Ryder]

  Cantor Fitzgerald set a $15.00 target price on Cidara Therapeutics (NASDAQ:CDTX) in a report released on Tuesday morning. The firm currently has a buy rating on the biotechnology company’s stock.

• [By Stephan Byrd]

  These are some of the media headlines that may have impacted Accern Sentiment’s analysis:

  Get Cidara Therapeutics alerts: Cidara Therapeutics (CDTX) Upgraded to Buy at WBB Securities (americanbankingnews.com) Data to be Presented at ASM Microbe 2018 Demonstrate the Efficacy and Safety of Cidara's Rezafungin for the Treatment of Invasive Fungal Infections (finance.yahoo.com) Cidara Therapeutics and Rutgers University awarded $5.5M grant from NIH to develop immunotherapy agents targeting gram-negative bacterial infections (seekingalpha.com) Cidara Therapeutics Announces Offering of Common Stock and Warrants (finance.yahoo.com) Cidara Therapeutics and Rutgers University Awarded $5.5 Million Grant from NIH to Support Development of Novel Immunotherapy Agents Targeting Multi-drug Resistant Gram-negative Bacterial Infections (finance.yahoo.com)

  Shares of CDTX stock traded up $0.30 during trading on Wednesday, hitting $5.20. 311,700 shares of the company were exchanged, compared to its average volume of 203,168. The company has a debt-to-equity ratio of 0.15, a quick ratio of 5.99 and a current ratio of 5.99. The stock has a market cap of $97.33 million, a P/E ratio of -1.64 and a beta of 2.05. Cidara Therapeutics has a twelve month low of $3.70 and a twelve month high of $8.80.

Top 10 Performing Stocks To Watch Right Now: 21Vianet Group, Inc.(VNET)

Advisors' Opinion:

• [By Joseph Griffin]

  BidaskClub upgraded shares of 21Vianet Group (NASDAQ:VNET) from a sell rating to a hold rating in a research report released on Tuesday.

  A number of other equities research analysts have also recently issued reports on VNET. ValuEngine upgraded shares of 21Vianet Group from a sell rating to a hold rating in a report on Wednesday, May 2nd. Zacks Investment Research upgraded shares of 21Vianet Group from a hold rating to a buy rating and set a $8.75 price objective for the company in a report on Thursday, May 24th.

• [By Joseph Griffin]

  21Vianet Group Inc (NASDAQ:VNET) rose 5.8% during mid-day trading on Thursday . The stock traded as high as $8.30 and last traded at $8.27. Approximately 927,613 shares changed hands during mid-day trading, an increase of 101% from the average daily volume of 460,831 shares. The stock had previously closed at $7.82.

• [By Money Morning News Team]

  Seadrill's rally demonstrates how profitable penny stocks can be for savvy investors. With Seadrill's gains already on the books, we'll look at a stock that's on track to generate tremendous returns – a small cap that just completed a groundbreaking acquisition with huge profit potential…

  Penny Stock Current Share Price Law Week's Gain Seadrill Ltd. (NYSE: SDRL) $0.58 98.74% Vivis Inc. (Nasdaq: VVUS) $0.83 59.97% MEI Pharma Inc. (Nasdaq: MEIP) $3.45 43.40% Transenterix Inc. (NYSE: TRXC) $3.15 35.72% Akers Biosciences Inc. (Nasdaq: AKER) $0.65 34.38% Galectin Therapeutics Inc. (Nasdaq: GALT) $4.54 32.58% Phoenix New Media Ltd. (NYSE ADR: FENG) $5.65 32.22% Heat Biologics Inc. (Nasdaq: HTBX) $1.73 31.37% Bright Scholar Education Ltd. (NYSE ADR: BEDU) $18.51 29.03% 21 Vianet Group Inc. (Nasdaq: VNET) $7.36 28.72%

  These gains are incredibly exciting. However, not all penny stocks are equally strong investments.

• [By Ethan Ryder]

  21Vianet Group (NASDAQ:VNET) will be issuing its quarterly earnings data after the market closes on Monday, March 4th. Analysts expect the company to announce earnings of $0.10 per share for the quarter.

• [By Stephan Byrd]

  21Vianet Group (NASDAQ:VNET) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Tuesday.

• [By Logan Wallace]

  Media stories about 21Vianet Group (NASDAQ:VNET) have been trending somewhat positive on Tuesday, Accern reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. 21Vianet Group earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned news headlines about the information technology services provider an impact score of 46.0521661520356 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Top 10 Performing Stocks To Watch Right Now: Balchem Corporation(BCPC)

Advisors' Opinion:

• [By Logan Wallace]

  JPMorgan Chase & Co. boosted its position in shares of Balchem Co. (NASDAQ:BCPC) by 20.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,196 shares of the basic materials company’s stock after buying an additional 12,487 shares during the period. JPMorgan Chase & Co.’s holdings in Balchem were worth $5,985,000 at the end of the most recent quarter.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Balchem (BCPC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Balchem Co. (NASDAQ:BCPC) – Equities research analysts at Seaport Global Securities lifted their Q2 2019 EPS estimates for shares of Balchem in a report issued on Thursday, February 28th. Seaport Global Securities analyst B. Hundley now forecasts that the basic materials company will post earnings per share of $0.81 for the quarter, up from their prior forecast of $0.80. Seaport Global Securities currently has a “Neutral” rating on the stock. Seaport Global Securities also issued estimates for Balchem’s Q3 2019 earnings at $0.78 EPS, Q4 2019 earnings at $0.83 EPS, FY2019 earnings at $3.15 EPS and FY2020 earnings at $3.30 EPS.

• [By Travis Hoium]

  Nearly every business Balchem (NASDAQ:BCPC) is in has seen strong growth in 2018, and that's driving the company's financial results higher. Fracking is seeing the biggest growth, but human and animal health continue to be great businesses for the company. 

Top 10 Performing Stocks To Watch Right Now: Pingtan Marine Enterprise Ltd.(PME)

Advisors' Opinion:

• [By Stephan Byrd]

  Pingtan Marine Enterprise (NASDAQ:PME) CEO Xinrong Zhuo purchased 50,000 shares of Pingtan Marine Enterprise stock in a transaction on Thursday, May 17th. The shares were acquired at an average price of $3.66 per share, with a total value of $183,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

• [By Stephan Byrd]

  Pingtan Marine Enterprise Ltd (NASDAQ:PME) CEO Xinrong Zhuo purchased 50,000 shares of the company’s stock in a transaction on Friday, May 25th. The shares were purchased at an average price of $3.33 per share, for a total transaction of $166,500.00. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website.

Top 10 Performing Stocks To Watch Right Now: Monmouth Real Estate Investment Corporation(MNR)

Advisors' Opinion:

• [By Max Byerly]

  M&T Bank Corp trimmed its position in Monmouth R.E. Inv. Corp. (NYSE:MNR) by 2.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 109,456 shares of the real estate investment trust’s stock after selling 2,301 shares during the period. M&T Bank Corp’s holdings in Monmouth R.E. Inv. were worth $1,358,000 at the end of the most recent reporting period.

• [By Ethan Ryder]

  Eagle Asset Management Inc. boosted its holdings in Monmouth R.E. Inv. Corp. (NYSE:MNR) by 0.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 524,288 shares of the real estate investment trust’s stock after purchasing an additional 1,268 shares during the quarter. Eagle Asset Management Inc. owned 0.57% of Monmouth R.E. Inv. worth $6,501,000 at the end of the most recent reporting period.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Monmouth Real Estate Investment (MNR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Watch Right Now: Matador Resources Company(MTDR)

Advisors' Opinion:

• [By Shane Hupp]

  Several institutional investors and hedge funds have recently made changes to their positions in MTDR. Rehmann Capital Advisory Group raised its position in shares of Matador Resources by 1,042.9% in the 4th quarter. Rehmann Capital Advisory Group now owns 1,863 shares of the energy company’s stock valued at $29,000 after purchasing an additional 1,700 shares in the last quarter. Nisa Investment Advisors LLC raised its position in shares of Matador Resources by 64.5% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,550 shares of the energy company’s stock valued at $40,000 after purchasing an additional 1,000 shares in the last quarter. Oregon Public Employees Retirement Fund raised its position in shares of Matador Resources by 1,453.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 634,633 shares of the energy company’s stock valued at $41,000 after purchasing an additional 593,768 shares in the last quarter. NumerixS Investment Technologies Inc raised its position in shares of Matador Resources by 89.4% in the 4th quarter. NumerixS Investment Technologies Inc now owns 8,002 shares of the energy company’s stock valued at $124,000 after purchasing an additional 3,777 shares in the last quarter. Finally, Dupont Capital Management Corp acquired a new position in shares of Matador Resources in the 4th quarter valued at approximately $152,000. 88.12% of the stock is currently owned by institutional investors.

  TRADEMARK VIOLATION NOTICE: “Matador Resources (MTDR) Shares Up 6%” was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright law. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/4155370/matador-resources-mtdr-shares-up-6.html.

  About Matador Resources (NYSE:MT

• [By Ethan Ryder]

  Matador Resources Co (NYSE:MTDR) – Stock analysts at Imperial Capital raised their Q3 2018 earnings per share (EPS) estimates for Matador Resources in a report issued on Thursday, October 4th. Imperial Capital analyst I. Haas now anticipates that the energy company will post earnings of $0.43 per share for the quarter, up from their prior forecast of $0.41. Imperial Capital currently has a “Outperform” rating and a $45.00 price objective on the stock. Imperial Capital also issued estimates for Matador Resources’ Q4 2018 earnings at $0.43 EPS, FY2018 earnings at $1.63 EPS, Q1 2019 earnings at $0.41 EPS, Q2 2019 earnings at $0.45 EPS, Q3 2019 earnings at $0.49 EPS, Q4 2019 earnings at $0.60 EPS and FY2019 earnings at $1.96 EPS.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Matador Resources (MTDR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Matador Resources (MTDR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Watch Right Now: Hancock Holding Company(HBHC)

Advisors' Opinion:

• [By Max Byerly]

  Wells Fargo & Company MN boosted its stake in shares of Hancock Holding (NASDAQ:HBHC) by 9.0% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,114,046 shares of the financial services provider’s stock after purchasing an additional 92,265 shares during the period. Wells Fargo & Company MN’s holdings in Hancock were worth $51,970,000 at the end of the most recent quarter.

Top 10 Performing Stocks To Watch Right Now: Constellium N.V.(CSTM)

Advisors' Opinion:

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Constellium (CSTM)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  ValuEngine cut shares of Constellium (NYSE:CSTM) from a strong-buy rating to a buy rating in a research note issued to investors on Tuesday.

  Several other analysts also recently weighed in on the stock. Morgan Stanley set a $15.00 price target on shares of Constellium and gave the stock a buy rating in a research note on Wednesday, February 28th. Societe Generale downgraded shares of Constellium from a buy rating to a hold rating in a research note on Wednesday, February 28th. Seaport Global Securities raised shares of Constellium from a neutral rating to a buy rating and boosted their price target for the stock from $14.00 to $16.00 in a research note on Friday, April 27th. Goldman Sachs Group began coverage on shares of Constellium in a research note on Tuesday, March 20th. They issued a buy rating and a $16.00 price target for the company. Finally, BMO Capital Markets boosted their price target on shares of Constellium from $13.00 to $14.00 and gave the stock a market perform rating in a research note on Friday, April 27th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Constellium currently has an average rating of Buy and a consensus price target of $16.20.

• [By Logan Wallace]

  Motley Fool Wealth Management LLC grew its position in shares of Constellium NV (NYSE:CSTM) by 4.6% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 522,644 shares of the industrial products company’s stock after purchasing an additional 22,954 shares during the period. Motley Fool Wealth Management LLC owned approximately 0.50% of Constellium worth $5,383,000 as of its most recent SEC filing.

• [By Shane Hupp]

  Deutsche Bank set a $15.00 price objective on Constellium (NYSE:CSTM) in a research note published on Tuesday morning. The brokerage currently has a buy rating on the industrial products company’s stock.